These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2649464)

  • 1. Micropharmacokinetics of chemical modifiers.
    Workman P
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):897-906. PubMed ID: 2649464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
    Kagiya VT; Nishimoto S; Ito T; Wang J; Abe M; Sasai K
    Int J Radiat Oncol Biol Phys; 1992; 22(3):601-5. PubMed ID: 1735699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
    Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro 03-8799: preferential relative uptake in human tumor xenografts compared to a murine tumor: comparison with SR-2508.
    Lespinasse F; Thomas C; Bonnay M; Malaise EP; Guichard M
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1105-9. PubMed ID: 2522920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumor hypoxia.
    Mannan RH; Mercer JR; Wiebe LI; Kumar P; Somayaji VV; Chapman JD
    J Nucl Biol Med (1991); 1992; 36(1):60-7. PubMed ID: 1450228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
    Hori H; Murayama C; Mori T; Shibamoto Y; Abe M; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1029-32. PubMed ID: 2703381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the melanin content of a human melanoma cell line and its radiosensitivity and uptake of pimonidazole.
    el Gamoussi R; Threadgill MD; Prade M; Stratford IJ; Guichard M
    Cancer Chemother Pharmacol; 1993; 31(4):277-82. PubMed ID: 8422690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of tumor affinity of nitroazoles in hypoxic radiosensitization.
    Kagiya T; Nishimoto S; Shibamoto Y; Wang J; Zhou L; He YL; Sasai K; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1033-7. PubMed ID: 2703382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and subcellular localization of radiosensitizers.
    Stratford MR
    BJR Suppl; 1992; 24():100-4. PubMed ID: 1290683
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer: evidence of diffusion from urine.
    Awwad HK; el Badawy S; abd el Baki H; Zaghloul M; el Moneim Osman A; Akoush H; Fairchild K
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1083-4. PubMed ID: 2522918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melanin.
    Laurent F; Canal P; Soula G
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1101-3. PubMed ID: 2703390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and additivity of the radiosensitizing effects of Ro 03-8799 and SR-2508 in mammalian cells in vitro.
    Watts ME; Dennis MF; Woodcock M
    Br J Radiol; 1987 Dec; 60(720):1233-5. PubMed ID: 2961396
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumour radiosensitization by clofibrate and its analogs: possible mechanisms.
    Hirst DG
    Adv Exp Med Biol; 1990; 277():917-25. PubMed ID: 2151413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C; Mori T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man.
    Workman P; Newman HF; Bleehen NM; Ward R; Smithen CE
    Cancer Chemother Pharmacol; 1991; 28(2):118-22. PubMed ID: 2060082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated elimination of pimonidazole following microsomal enzyme induction in mice: a possible approach to reduced neurotoxicity of the pimonidazole-etanidazole combination.
    Workman P
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1011-4. PubMed ID: 2522916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
    Papadopoulou MV; Pouremad R; Bloomer WD; Wyrwicz A
    Anticancer Res; 2006; 26(5A):3259-63. PubMed ID: 17094438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain.
    Kagiya VT; Sugita T; Nishimoto S; Masuoka M; Zhou L; Abe M; Shibamoto Y; Sasai K
    Int J Radiat Oncol Biol Phys; 1992; 22(3):597-600. PubMed ID: 1735698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.